Adamas Pharmaceuticals develops innovative treatments for chronic neurologic disorders.
View all
Nabriva Therapeutics
Post IPO Equity • King of Prussia, United States
Stemline Therapeutics
Post IPO Equity • New York, United States
Corvus Pharmaceuticals
Post IPO Equity • Burlingame, United States
Magenta Therapeutics
Post IPO Equity • Cambridge, United States
C4 Therapeutics
Post IPO Equity • Cambridge, United States
Axsome Therapeutics
Post IPO Equity • New York, United States
Krystal Biotech
Post IPO Equity • Pittsburgh, United States
Catalyst Pharmaceuticals
Post IPO Equity • Coral Gables, United States
Translate Bio
Post IPO Equity • Lexington, United States
Arbutus Biopharma
Post IPO Equity • Warminster, United States
Quince Therapeutics
Post IPO Equity • South San Francisco, United States
Jounce Therapeutics
Post IPO Equity • Cambridge, United States